Abstract
The pathophysiology of chronic kidney disease–mineral and bone disorder accounts for an inverse relationship between bone mineralization and vascular calcification in progressive nephropathy. Inverse associations between bone mineral density (BMD) and calcified atherosclerotic plaque are also observed in individuals of European and African ancestry without nephropathy, suggesting a mechanistic link between these processes that is independent of kidney disease. Despite lower dietary calcium intake and serum 25-hydroxyvitamin D (25(OH)D) concentrations, African Americans have higher BMD and develop osteoporosis less frequently than do European Americans. Moreover, despite having more risk factors for cardiovascular disease, African Americans have a lower incidence and severity of calcified atherosclerotic plaque formation than do European Americans. Strikingly, evidence is now revealing that serum 25(OH)D and/or 1,25 dihydroxyvitamin D levels associate positively with atherosclerosis but negatively with BMD in African Americans; by contrast, vitamin D levels associate negatively with atherosclerosis and positively with BMD in individuals of European ancestry. Biologic phenomena, therefore, seem to contribute to population-specific differences in vitamin D metabolism, bone and vascular health. Genetic and mechanistic approaches used to explore these differences should further our understanding of bone–blood vessel relationships and explain how African ancestry protects from osteoporosis and calcified atherosclerotic plaque, provided that access of African Americans to health care is equivalent to individuals of European ethnic origin. Ultimately, in our opinion, a new mechanistic understanding of the relationships between bone mineralization and vascular calcification will produce novel approaches for disease prevention in aging populations.
Key Points
-
Inverse relationships exist between bone mineral density (BMD) and calcified atherosclerotic plaque in individuals of European and African ancestry without nephropathy
-
African Americans have higher BMD and develop osteoporosis less often than do European Americans, despite lower serum 25-hydroxyvitamin D levels and dietary calcium intake
-
European Americans have higher incidence rates and severity of calcified atherosclerotic plaque relative to African Americans despite fewer cardiovascular disease risk factors
-
Inherited phenomena are likely to contribute to population-specific differences in vitamin D metabolism, vascular calcification, and bone mineralization
-
Molecular genetic approaches will enhance our understanding of bone and vascular health
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hruska, K. A. et al. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr. Nephrol. 25, 769–778 (2010).
Isakova, T. et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J. Am. Soc. Nephrol. 19, 615–623 (2008).
Anderson, J., Barnett, E. & Nordin, B. E. The relation between osteoporosis and aortic calcification. Br. J. Radiol. 37, 910–912 (1964).
Elkeles, A. A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet 273, 714–715 (1957).
Browner, W. S. et al. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24, 940–946 (1993).
Kiel, D. P. et al. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif. Tissue Int. 68, 271–276 (2001).
Marcovitz, P. A. et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am. J. Cardiol. 96, 1059–1063 (2005).
Ness, J. & Aronow, W. S. Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia. Am. J. Cardiol. 97, 1427–1428 (2006).
Silverman, S. L. et al. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. J. Am. Geriatr. Soc. 52, 1543–1548 (2004).
Tanko, L. B. et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J. Bone Miner. Res. 20, 1912–1920 (2005).
Schulz, E. et al. Aortic calcification and the risk of osteoporosis and fractures. J. Clin. Endocrinol. Metab. 89, 4246–4253 (2004).
Carr, J. J. et al. Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone 42, 43–52 (2008).
Divers, J. et al. Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J. Bone Miner. Res. 26, 1554–1560 (2011).
Hofbauer, L. C. et al. Vascular calcification and osteoporosis-—from clinical observation towards molecular understanding. Osteoporos. Int. 18, 251–259 (2007).
Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78–81 (1997).
Speer, M. Y. et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J. Exp. Med. 196, 1047–1055 (2002).
Schafer, C. et al. The serum protein α-2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112, 357–366 (2003).
Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45–51 (1997).
Bucay, N. et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260–1268 (1998).
Abedin, M. et al. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am. J. Cardiol. 99, 513–518 (2007).
Doherty, T. M. et al. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin. Proc. 79, 197–210 (2004).
Abedin, M., Tintut, Y. & Demer, L. L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 24, 1161–1170 (2004).
Demer, L. L. & Tintut, Y. Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler. Thromb. Vasc. Biol. 23, 1739–1743 (2003).
Giachelli, C. M. et al. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ. Res. 96, 717–722 (2005).
Demer, L. L. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int. J. Epidemiol. 31, 737–741 (2002).
Irving, J. T. & Wuthier, R. E. Histochemistry and biochemistry of calcification with special reference to the role of lipids. Clin. Orthop. Relat. Res. 56, 237–260 (1968).
Cotmore, J. M., Nichols, G. Jr & Wuthier, R. E. Phospholipid-calcium phosphate complex: enhanced calcium migration in the presence of phosphate. Science 172, 1339–1341 (1971).
Ennever, J., Vogel, J. J. & Riggan, L. J. Calcification by proteolipid from atherosclerotic aorta. Atherosclerosis 35, 209–213 (1980).
Register, T. C., McLean, F. M., Low, M. G. & Wuthier, R. E. Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer. Biol. Chem. 261, 9354–9360 (1986).
Shanahan, C. M. et al. Expression of mineralisation-regulating proteins in association with human vascular calcification. Z. Kardiol. 89 (Suppl. 2), 63–68 (2000).
Burton, D. G., Matsubara, H. & Ikeda, K: Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells. Exp. Gerontol. 45, 819–824 (2010).
Giachelli, C. M. Vascular calcification mechanisms. J. Am. Soc. Nephrol. 15, 2959–2964 (2004).
Ellam, T. J. & Chico, T. J. Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220, 310–318 (2012).
Aloia, J. F. et al. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am. J. Clin. Nutr. 84, 602–609 (2006).
Acheson, L. S. Bone density and the risk of fractures: should treatment thresholds vary by race? JAMA 293, 2151–2154 (2005).
Aloia, J. F. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am. J. Clin. Nutr. 88, 545S–550S (2008).
Rostand, S. G. Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis. Clin. J. Am. Soc. Nephrol. 5, 1697–1703 (2010).
George, A. et al. Racial differences in bone mineral density in older men. J. Bone Miner. Res. 18, 2238–2244 (2003).
Looker, A. C., Melton, L. J. III, Borrud, L. G. & Shepherd, J. A. Lumbar spine bone mineral density in US adults: demographic patterns and relationship with femur neck skeletal status. Osteoporos. Int. 23, 1351–1360 (2012).
Ross, A. C. et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53–58 (2011).
Shapses, S. A. & Manson, J. E. Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA 305, 2565–2566 (2011).
Ross, A. C., Taylor, C. L. & Yaktine, A. L. (Eds) Dietary reference intakes for calcium and vitamin D (The National Academies Press, Washington DC, 2011).
Bell, N. H. et al. Evidence for alteration of the vitamin D-endocrine system in blacks. J. Clin. Invest. 76, 470–473 (1985).
Bell, N. H. et al. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J. Bone Miner. Res. 8, 1111–1115 (1993).
Hustmyer, F. G., DeLuca, H. F. & Peacock, M. ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. Hum. Mol. Genet. 2, 487 (1993).
Freedman, B. I. et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African Americans. J. Clin. Endocrinol. Metab. 95, 1076–1083 (2010).
Detrano, R. et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358, 1336–1345 (2008).
Agarwal, S. et al. Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study. Diabetes Care 34, 1219–1224 (2011).
Aloia, J. F., Talwar, S. A., Pollack, S. & Yeh, J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch. Intern. Med. 165, 1618–1623 (2005).
Cauley, J. A. et al. Serum 25 hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's health initiative (WHI). J. Bone Miner. Res. 26, 2378–2388 (2011).
Davies, M. R. & Hruska, K. A. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 60, 472–479 (2001).
Wolf, M. et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J. Am. Soc. Nephrol. 19, 1379–1388 (2008).
Kalantar-Zadeh, K. et al. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J. Bone Miner. Res. 25, 2724–2734 (2010).
Dent, C. E., Engelbrecht, H. E. & Godfrey, R. C. Osteoporosis of lumbar vertebrae and calcification of abdominal aorta in women living in Durban. Br. Med. J. 4, 76–79 (1968).
Newby, P. K. et al. Race and region are associated with nutrient intakes among black and white men in the United States. J. Nutr. 141, 296–303 (2011).
Bersaglieri, T. et al. Genetic signatures of strong recent positive selection at the lactase gene. Am. J. Hum. Genet. 74, 1111–1120 (2004).
Swallow, D. M. Genetics of lactase persistence and lactose intolerance. Annu. Rev. Genet. 37, 197–219 (2003).
Cosman, F. et al. Resistance to bone resorbing effects of PTH in black women. J. Bone Miner. Res. 12, 958–966 (1997).
Stamatelou, K. K. et al. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 63, 1817–1823 (2003).
Gutierrez, O. M. et al. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrol. Dial. Transplant. 25, 3970–3977 (2010).
Yokoyama, K. et al. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease. Kidney Int. 53, 454–458 (1998).
Shao, J. S. et al. Teriparatide (human parathyroid hormone (1–34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J. Biol. Chem. 278, 50195–50202 (2003).
Thorleifsson, G. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41, 926–930 (2009).
Newman, A. B. et al. Racial differences in coronary artery calcification in older adults. Arterioscler. Thromb. Vasc. Biol. 22, 424–430 (2002).
Freedman, B. I. et al. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Diabetologia 48, 2511–2518 (2005).
Bild, D. E. et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111, 1313–1320 (2005).
Carnethon, M. R. et al. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: the Multiethnic Study of Atherosclerosis. Diabetes Care 28, 2768–2770 (2005).
Budoff, M. J. et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 187, 343–350 (2006).
American Diabetes Association. http://www.diabetes.org
Young, B. A., Maynard, C. & Boyko, E. J. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26, 2392–2399 (2003).
Karter, A. J. et al. Ethnic disparities in diabetic complications in an insured population. JAMA 287, 2519–2527 (2002).
Young, B. A. et al. Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS. Kidney Int. 69, 1691–1698 (2006).
Buckalew, V. M. Jr & Freedman, B. I. Effects of race on albuminuria and risk of cardiovascular and kidney disease. Expert Rev. Cardiovasc. Ther. 9, 245–249 (2011).
Collins, A. J. et al. United States Renal Data System. USRDS 2011 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am. J. Kidney Dis. 59 (Suppl. 1), e1–e420 (2012).
Kucirka, L. M. et al. Association of race and age with survival among patients undergoing dialysis. JAMA 306, 620–626 (2011).
Buckalew, V. M. & Freedman, B. I. Reappraisal of the impact of race on survival in patients on dialysis. Am. J. Kidney Dis. 55, 1102–1110 (2010).
Jain, T. et al. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J. Am. Coll. Cardiol. 44, 1011–1017 (2004).
Wagenknecht, L. E. et al. Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes. Ann. Epidemiol. 21, 34–41 (2011).
Wassel, C. L. et al. Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the multi-ethnic study of atherosclerosis. Circ. Cardiovasc. Genet. 2, 629–636 (2009).
Divers, J. et al. Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study. J. Clin. Endocrinol. Metab. 95, 5382–5389 (2010).
Divers, J. et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study. Diabetes Care 33, 131–138 (2010).
Wang, T. J. et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376, 180–188 (2010).
Shen, H. et al. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler. Thromb. Vasc. Biol. 30, 2648–2654 (2010).
Freedman, B. I. et al. Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J. Bone Miner. Res. 24, 1719–1727 (2009).
Smith, M. W. et al. A high-density admixture map for disease gene discovery in african americans. Am. J. Hum. Genet. 74, 1001–1013 (2004).
Divers, J., Moossavi, S., Langefeld, C. D. & Freedman, B. I. Genetic admixture: a tool to identify diabetic nephropathy genes in African Americans. Ethn. Dis. 18, 384–388 (2008).
Kopp, J. B. et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 40, 1175–1184 (2008).
Kao, W. H. et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 40, 1185–1192 (2008).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Freedman, B. I. et al. The Apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol. 21, 1422–1426 (2010).
Ferguson, R., Grim, C. E. & Opgenorth, T. J. A familial risk of chronic renal failure among blacks on dialysis? J. Clin. Epidemiol. 41, 1189–1196 (1988).
Freedman, B. I., Spray, B. J., Tuttle, A. B. & Buckalew, V. M. Jr. The familial risk of end-stage renal disease in African Americans. Am. J. Kidney Dis. 21, 387–393 (1993).
Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129–2137 (2011).
Razzaque, M. S. The dualistic role of vitamin D in vascular calcifications. Kidney Int. 79, 708–714 (2011).
Acknowledgements
The authors wish to thank D. W. Bowden, C. D. Langefeld, J. Divers, J. J. Carr, and N. Allred for their assistance with this work. This project was funded in part by NIH grant DK071891.
Author information
Authors and Affiliations
Contributions
Both authors contributed to all aspects of the article.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Freedman, B., Register, T. Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nat Rev Nephrol 8, 459–466 (2012). https://doi.org/10.1038/nrneph.2012.112
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.112
This article is cited by
-
25-hydroxyvitamin D serum level in children of different ethnicity living in Italy
European Journal of Pediatrics (2015)
-
Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD
Kidney International (2014)
-
Vitamin D and the Cardiovascular System: An Overview of the Recent Literature
American Journal of Cardiovascular Drugs (2014)
-
Cardiorespiratory fitness in older adult women: relationships with serum 25-hydroxyvitamin D
Endocrine (2014)
-
Genetic variant in vitamin D binding protein is associated with serum 25-hydroxyvitamin D and vitamin D insufficiency in southern Chinese
Journal of Human Genetics (2013)